【レポートの概要（一部）】
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, March 2013 9
2.2.1 Medtronic Completes Public Offering of Notes for $3 Billion 9
2.2.2 Lundbeck Enters into Licensing Agreement with Otsuka Pharma for Lu AE58054 9
2.2.3 Edison Pharma Enters Into Licensing Agreement with Dainippon Sumitomo Pharma for EPI-743 and EPI-589 10
2.2.4 Sinopharm Announces Private Placement of Shares for $525 Million 10
2.2.5 AstraZeneca Enters into Co-Development Agreement with Moderna Therapeutics for Messenger RNA Therapeutics 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, March 2013 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March 2013 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, March 2013 13
3.1.1 Top M&A Deals in March 2013 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, October 2012–March 2013 15
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, March 2013 16
3.2.1 Top Equity Offering Deals in March 2013 17
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, October 2012– March 2013 18
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, March 2013 19
3.3.1 Top PE/VC Deals in March 2013 20
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, March 2013 21
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, March 2013 22
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, October 2012– March 2013 24
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, October 2012– March 2013 25
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, October 2012– March 2013 27
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 28
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, March 2013 29
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), October 2012– March 2013 30
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, October 2012– March 2013 31
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), October 2012– March 2013 32
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), October 2012– March 2013 33
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2013 35
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, March 2013 36
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, March 2013 36
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, March 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), October 2012– March 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), October 2012– March 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, March 2013 43
6.1.1 Central Nervous System – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Oncology Deals, March 2013 45
6.2.1 Oncology – Deals of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, March 2013 47
6.3.1 Infectious Diseases – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, March 2013 49
6.4.1 Immunology – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, March 2013 51
6.5.1 Cardiovascular – Deal of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, March 2013 53
6.6.1 Gastrointestinal – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, March 2013 55
6.7.1 Metabolic Disorders – Deal of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, March 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, March 2013 59
7.2.1 Europe – Deals of the Month 60
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, March 2013 61
7.3.1 Asia-Pacific – Deals of the Month 62
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, March 2013 63
7.4.1 Rest of the World – Deals of the Month 64
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 65
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, October 2012– March 2013 65
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, October 2012– March 2013 66
9 Further Information 67
9.1 Methodology 67
9.2 About GlobalData 67
9.3 Contact Us 68
9.4 Disclosure information 68
9.5 Disclaimer 68
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：March 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
■ 発行日：2013年4月12日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160765
■ 調査対象地域：グローバル
- Dimethyl Succinateの世界市場Dimethyl Succinate(DMS) (CAS 106-65-0) Market Research Report 2013 presents comprehensive data on dimethyl succinate(dms) markets globally and regionally (Europe, Asia, North America etc.) The report includes dimethyl succinate(dms) description, covers its application areas and related patterns. It overviews dimethyl succinate(dms) market, names dimethyl succinate(dms) producers and indicates its …
- 世界のスペクトラムアナライザ（スペクトル分析器）市場（2014-2018）About Spectrum Analyzer A spectrum analyzer is a type of test equipment that measures the amplitude of the input signal as a function of frequency within the specified frequency range of the instrument. It is primarily used to measure and analyze the power of the spectrum of signals on different parameters. It is used mainly in the spectrum analysis of various waveforms, the measurement of field s …
- 2014年ドイツの分子血液型・分類検査および感染症NAT（核酸増幅検査）市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and …
- Linn Energy, LLC社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Linn Energy, LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Linn Energy, LLC (Linn Energy) is an independent upstream oil and gas company. The company undertakes development and acquisition of oil, natural gas liquids (NGL’s) and gas properties across the US. Linn Energy’s operations are geographically spread across the US in the following regions, namely, …
- 農業用接種剤の世界市場：植物成長促進微生物、生物防除剤、植物耐性刺激剤The agricultural inoculants market is projected to grow at a CAGR of 9.6% from 2015 to reach a projected value of USD 437.1 Million by 2020. The growth of this market is driven by the increase in demand of organic fertilizers in the agricultural sector. The market is further driven by factors such as increase in organic and environment-friendly farming practices, promotion by the government agenci …
- 萎縮性胃炎(Atrophic Gastritis)：世界の治験レビュー（2015年上半期版）Atrophic Gastritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Atrophic Gastritis Global Clinical Trials Review, H1, 2015" provides data on the Atrophic Gastritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophic Gastritis. It includes an overview of the trial numbers and their recruitme …
- C型肝炎ウイルス感染：グローバル治療薬の市場予測と分析PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the mar …
- YPF S.A.：石油・ガスの開発・生産動向及びコスト分析– 2012YPF S.A. Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary YPF S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, ana …
- 世界の金属表面処理用化学薬品市場2015The Global Metal Finishing Chemicals Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Metal Finishing Chemicals industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Metal Finishing Chemicals market analysis is provided for the international markets in …
- オトスコープ(耳鏡)の世界市場2018-2022About otoscopes Otoscopes are a medical device useful in assisting the physician in making a physical diagnosis of ear-related ailments such as infection, irritation, ear pain, ear discharge, and redness. Technavio’s analysts forecast the Global otoscopes market to grow at a CAGR of 4.02% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth pros …
- 世界の小売産業におけるIoT市場Internet of Things (IoT) is significantly adopted in every process of retailing such as advertising and marketing, smart kiosks, vending machines, inventory management, and customer payments. . The fact that IoT is rapidly connecting with these retailing processes is due to increasing internet ubiquity, and emergence of cloud platform. The declining cost of sensors and RFID have also significantly …
- バス用バックカメラの世界市場2017-2021About Bus RVC The major reason for the need for the RVCs than reverse parking sensors in buses is because of few drawbacks and unfavorable market dynamics in the reverse parking sensors market. The automotive parking sensors market is concentrated by OEMs, while aftermarket is fragmented with intense competition among the regional players, and this competition is expected to intensify further with …
- Aubagio (Multiple Sclerosis)：市場予測と分析（～2022）Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervo …
- ワクチンアジュバントの世界市場：粒子状アジュバント、アジュバント・エマルション、病原体、サポニン、組合せアジュバントThe global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets …
- 携帯型医療電子製品の世界市場：パルスオキシメーター、呼吸装置、血圧モニター、医療画像装置、心臓機能モニターAccording to Stratistics MRC, the global portable medical electronic products market is expected to grow from $55.4 billion in 2015 to $73.95 billion by 2022 at a CAGR of 4.21%. The portable medical electronic products market has been witnessing remarkable growth, mainly driven by increasing demand for safe and quality devices. Additionally, rising aging population, introduction of home healthcare …
